A detailed history of Schulhoff & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Schulhoff & CO Inc holds 6,210 shares of NVS stock, worth $615,286. This represents 0.32% of its overall portfolio holdings.

Number of Shares
6,210
Previous 6,210 -0.0%
Holding current value
$615,286
Previous $661,000 8.02%
% of portfolio
0.32%
Previous 0.32%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$92.57 - $107.37 $555 - $644
6 Added 0.1%
6,210 $661,000
Q1 2024

May 01, 2024

BUY
$95.27 - $108.47 $14,576 - $16,595
153 Added 2.53%
6,204 $600,000
Q2 2023

Aug 01, 2023

BUY
$92.52 - $104.91 $370 - $419
4 Added 0.07%
6,051 $610,000
Q2 2022

Aug 05, 2022

BUY
$80.52 - $93.75 $402 - $468
5 Added 0.08%
6,047 $511,000
Q2 2021

Aug 03, 2021

BUY
$85.24 - $94.15 $340 - $376
4 Added 0.07%
6,042 $551,000
Q2 2020

Jul 29, 2020

SELL
$80.93 - $91.1 $164,935 - $185,661
-2,038 Reduced 25.24%
6,038 $527,000
Q3 2019

Nov 01, 2019

SELL
$85.54 - $94.26 $76,986 - $84,834
-900 Reduced 10.03%
8,076 $701,000
Q2 2019

Aug 07, 2019

BUY
$75.4 - $92.8 $301 - $371
4 Added 0.04%
8,976 $819,000
Q4 2018

Feb 07, 2019

SELL
$73.66 - $82.02 $29,464 - $32,808
-400 Reduced 4.27%
8,972 $769,000
Q3 2018

Nov 07, 2018

BUY
$66.94 - $77.43 $20,082 - $23,229
300 Added 3.31%
9,372 $807,000
Q2 2018

Aug 03, 2018

BUY
$64.91 - $73.36 $19,797 - $22,374
305 Added 3.48%
9,072 $685,000
Q1 2018

Apr 26, 2018

BUY
$70.39 - $84.15 $281 - $336
4 Added 0.05%
8,767 $708,000
Q4 2017

Jan 26, 2018

BUY
$72.33 - $77.64 $14,466 - $15,528
200 Added 2.34%
8,763 $735,000
Q3 2017

Oct 25, 2017

BUY
$74.14 - $77.27 $17,793 - $18,544
240 Added 2.88%
8,563 $735,000
Q2 2017

Aug 08, 2017

BUY
N/A
8,323
8,323 $694,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Schulhoff & CO Inc Portfolio

Follow Schulhoff & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schulhoff & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schulhoff & CO Inc with notifications on news.